Category Archives: Pr Newswire

AeC Awarded Frost & Sullivan’s 2024 Brazil Company of the Year Award for Its Exceptional Customer Experience Management Solutions

AeC delivers top-notch customer experience (CX) services, enhances productivity, and fosters a customer-centric approach in the Brazilian industry by leveraging its highly advanced CX management (CXM) tools. SAN ANTONIO, Aug. 6, 2024 /PRNewswire/ — Frost & Sullivan recently researched the CXM industry and, based on its findings, recognizes AeC with the 2024 Brazil Company of the Year Award. […]

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team

TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture’s President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., […]

Mesa Labs Announces First Quarter Results

LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q25”) ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: […]

Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio

Friedreich Ataxia (FA) and Fuchs Endothelial Corneal Dystrophy (FECD) Programs on Track and Advancing Toward Clinical Trials Active Research Pipeline with Programs Progressing in Myotonic Dystrophy Type-1 (DM1) and Huntington’s Disease (HD) Cash and Securities of $261.0 Million Supports Operations Through Potentially Four Clinical Proof-of-Concept Data Sets CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) — […]

4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board

Dhaval Desai, PharmD, named as Chief Development Officer; will oversee late-stage Product Development, Medical Affairs, Scientific Communications, Regulatory and Quality operations; most recently SVP & Chief Development Officer at Iveric Bio where he led development and approval of IZERVAY Christopher Simms named as Chief Commercial Officer, effective September 25, 2024; will oversee Pre-commercial and Commercial […]

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide

Daxor’s ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities. Daxor’s ezBVA lab service is a state-of-the-art CLIA certified facility that […]

QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER

Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. Mr Doyle brings extensive knowledge in leading negotiations for pharmaceutical assets across a range of deal types, licensing deals across […]

Cloud Music Inc. to Report First Half 2024 Financial Results on August 22, 2024

HANGZHOU, China, Aug. 5, 2024 /PRNewswire/ — Cloud Music Inc. (HKEX: 9899 or the “Company”), a leading interactive music streaming service provider in China, today announced that it will report its financial results for the first half of 2024 ended June 30, 2024 on Thursday, August 22, 2024, after the Hong Kong market closes. The […]

JinkoSolar Announces Cash Dividend

SHANGRAO, China, Aug. 5, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors has declared a cash dividend of US$0.375 per ordinary share of US$0.00002 each of the Company (the “Ordinary Shares”), […]